imjudo

Frequently asked questions

What does Imjudo treat?

Imjudo (Tremelimumab-Actl) may be used to treat hepatocellular carcinoma, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.

Is there a coupon or discount for Imjudo?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Imjudo. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Who makes Imjudo?

Imjudo is marketed by Astrazeneca Ab. You can see Astrazeneca Ab's full profile, rating, and other products on pharmaranks.

Is Imjudo a brand-name or generic drug?

Imjudo is a brand-name product with the active ingredient Tremelimumab-Actl.

Is Imjudo available over the counter?

No. Imjudo is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Imjudo come in?

Imjudo is currently marketed as injectable, per the FDA's National Drug Code Directory.

Is Imjudo FDA-registered?

Imjudo is on record with the U.S. FDA under application number BLA761270. You can verify this on its official FDA label.